These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34808034)

  • 1. Laboratory management for large-scale population screening for SARS-CoV-2.
    Duan X; Lv D; Wang L; Liu Y; Zhang S; Liu W; Xie J; Gu C; Li X; Tao Z; Chen X; Yao Q
    Immun Inflamm Dis; 2022 Jan; 10(1):33-42. PubMed ID: 34808034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening High-Risk Groups and the General Population for SARS-CoV-2 Nucleic Acids in a Mobile Biosafety Laboratory.
    Guo Z; Li L; Song Y; Xu J; Huang J
    Front Public Health; 2021; 9():708476. PubMed ID: 34485233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital.
    Wang Q; Zhao X; Yue Z; Bai X; Rao H; Han N; Wang T; Wang H; Jiang B
    Emerg Microbes Infect; 2020 Dec; 9(1):2358-2360. PubMed ID: 33054582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses.
    Mukherjee TK; Malik P; Maitra R; Hoidal JR
    Curr Med Res Opin; 2021 Feb; 37(2):207-217. PubMed ID: 33306409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological features of severe acute respiratory syndrome coronavirus 2 infection in children in Shijiazhuang, China: an analysis of 133 cases].
    Lu SK; Niu B; Ji LL; Liu JH; Shuai JF
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 May; 23(5):456-459. PubMed ID: 34020733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.
    Pan Y; Long L; Zhang D; Yuan T; Cui S; Yang P; Wang Q; Ren S
    Clin Chem; 2020 Jun; 66(6):794-801. PubMed ID: 32246822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
    Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
    JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
    Zheng S; Fan J; Yu F; Feng B; Lou B; Zou Q; Xie G; Lin S; Wang R; Yang X; Chen W; Wang Q; Zhang D; Liu Y; Gong R; Ma Z; Lu S; Xiao Y; Gu Y; Zhang J; Yao H; Xu K; Lu X; Wei G; Zhou J; Fang Q; Cai H; Qiu Y; Sheng J; Chen Y; Liang T
    BMJ; 2020 Apr; 369():m1443. PubMed ID: 32317267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expert advice on management of urban nucleic acid testing base].
    ; ; ;
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jun; 55(6):720-726. PubMed ID: 34139810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.
    Gupta N; Potdar V; Praharaj I; Giri S; Sapkal G; Yadav P; Choudhary ML; Dar L; Sugunan AP; Kaur H; Munivenkatappa A; Shastri J; Kaveri K; Dutta S; Malhotra B; Jain A; Nagamani K; Shantala GB; Raut S; Vegad MM; Sharma A; Choudhary A; Brijwal M; Balakrishnan A; Manjunatha J; Pathak M; Srinivasan S; Banu H; Sharma H; Jain P; Sunita P; Ambica R; Fageria B; Patel D; Rajbongshi G; Vijay N; Narayan J; Aggarwal N; Nagar A; Gangakhedkar RR; Abraham P
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):216-225. PubMed ID: 32242875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory.
    Williams E; Bond K; Chong B; Giltrap D; Eaton M; Kyriakou P; Calvert P; Zhang B; Siwan M; Howden B; Druce J; Catton M; Williamson DA
    Pathology; 2020 Dec; 52(7):754-759. PubMed ID: 32943228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.
    Campbell JR; Uppal A; Oxlade O; Fregonese F; Bastos ML; Lan Z; Law S; Oh CE; Russell WA; Sulis G; Winters N; Yanes-Lane M; Brisson M; Laszlo S; Evans TG; Menzies D
    CMAJ; 2020 Oct; 192(40):E1146-E1155. PubMed ID: 32907820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test Results.
    Robinson-McCarthy LR; Mijalis AJ; Filsinger GT; de Puig H; Donghia NM; Schaus TE; Rasmussen RA; Ferreira R; Lunshof JE; Chao G; Ter-Ovanesyan D; Dodd O; Kuru E; Sesay AM; Rainbow J; Pawlowski AC; Wannier TM; Angenent-Mari NM; Najjar D; Yin P; Ingber DE; Tam JM; Church GM
    Microbiol Spectr; 2021 Oct; 9(2):e0031321. PubMed ID: 34523989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mirror Technology Facilitates High-Throughput, Accurate SARS-CoV-2 Testing.
    Realegeno S; Hash S; Wong C; Liu R; Shepherd J; Schooley RT; Lipson DA; Fung F; Menon S; Pride DT
    Microbiol Spectr; 2021 Sep; 9(1):e0039221. PubMed ID: 34431687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the diagnostic efficacy between two PCR test kits for SARS-CoV-2 nucleic acid detection.
    Lu Y; Li L; Ren S; Liu X; Zhang L; Li W; Yu H
    J Clin Lab Anal; 2020 Oct; 34(10):e23554. PubMed ID: 32977349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.